Gene expression profiling and functional activity of human dendritic cells induced with IFN-α-2b: Implications for cancer immunotherapy

Clinical Cancer Research

Volumn 9, Issue 6, 2003, Pages 2022-2031

  Moschella, Federica ^b   Bisikirska, Brygida ^b   Maffei, Antonella ^a   Papadopoulos, Kyriakos P ^b   Skerrett, Donna ^b   Liu, Zhuoru ^b   Hesdorffer, Charles S ^b   Harris, Paul E ^b,c  

^a INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

^b Columbia University ^*  (United States)

^c Division of Medical Oncology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CELL PROTEIN; CHEMOKINE; CHEMOKINE RECEPTOR; CYTOKINE; INTERLEUKIN 15; INTERLEUKIN 1BETA; INTERLEUKIN 4; MESSENGER RNA; RECOMBINANT ALPHA2B INTERFERON; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADOPTIVE TRANSFER; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER IMMUNOTHERAPY; CELL MEDIATED CYTOTOXICITY; CYTOKINE PRODUCTION; DENDRITIC CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; INTERNALIZATION; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; DENDRITIC CELLS; GENE EXPRESSION PROFILING; GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTORS, RECOMBINANT; HUMANS; IMMUNOPHENOTYPING; IMMUNOTHERAPY, ADOPTIVE; INTERFERON ALFA-2B; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; NEOPLASMS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0038515256     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Dowding, C., Gordon, M., Guo, A. P., Maison, D., Osterholz, J., Siczkowski, M., and Goldman, J. Potential mechanisms of action of interferon-α in CML. Leuk. Lymphoma, 11: 185-191, 1993.
2. Wetzler, M., Kantarjian, H., Kurzrock, R., and Talpaz, M. Interferon-α therapy for chronic myelogenous leukemia. Am. J. Med., 99: 402-411, 1995.
3. Kirkwood, J. M., Ibrahim, J. G., Sosman, J. A., Sondak, V. K., Agarwala, S. S., Ernstoff, M. S., and Rao, U. High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801. J. Clin. Oncol., 19: 2370-2380, 2001.
4. Biron, C. A. Interferons α and β as immune regulators - a new look. Immunity, 14: 661-664, 2001.
5. Minasian, L. M., Motzer, R. J., Gluck, L., Mazumdar, M., Vlamis, V., and Krown, S. E. Interferon alfa-2a in advanced renal cell carcinoma: treatment results and survival in 159 patients with long-term follow-up. J. Clin. Oncol., 11: 1368-1375, 1993.
6. Vial, T., and Descotes, J. Clinical toxicity of the interferons. Drug Saf., 10: 115-150, 1994.
7. Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y. J., Pulendran, B., and Palucka, K. Immunobiology of dendritic cells. Annu Rev Immunol, 18: 767-811, 2000.
8. Liu, Y. J. Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell, 106: 259-262, 2001.
9. Sallusto, F., Palermo, B., Lenig, D., Miettinen, M., Matikainen, S., Julkunen, I., Forster, R., Burgstahler, R., Lipp, M., and Lanzavecchia, A. Distinct patterns and kinetics of chemokine production regulate dendritic cell function. Eur. J. Immunol., 29: 1617-1625, 1999.
10. Sallusto, F., Palermo, B., Hoy, A., and Lanzavecchia, A. The role of chemokine receptors in directing traffic of naive, type 1 and type 2 T cells. Curr. Top. Microbiol. Immunol., 246: 123-128, 1999.
11. Moschella, F., Maffei, A., Catanzaro, R. P., Papadopoulos, K. P., Skerrett, D., Hesdorffer, C. S., and Harris, P. E. Transcript profiling of human dendritic cells maturation-induced under defined culture conditions: comparison of the effects of tumour necrosis factor α, soluble CD40 ligand trimer and interferon γ. Br. J. Haematol., 114: 444-457, 2001.
12. Montoya, M., Schiavoni, G., Mattei, F., Gresser, I., Belardelli, F., Borrow, P., and Tough, D. F. Type I interferons produced by dendritic cells promote their phenotypic and functional activation. Blood, 99: 3263-3271, 2002.
13. Luft, T., Pang, K. C., Thomas, E., Hertzog, P., Hart, D. N., Trapani, J., and Cebon, J. Type 1 IFNs enhance the terminal differentiation of dendritic cells. J. Immunol., 161: 1947-1953, 1998.
14. Santini, S. M., Lapenta, C., Logozzi, M., Parlato, S., Spada, M., Di Pucchio, T., and Belardelli, F. Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice. J. Exp. Med., 191: 1777-1788, 2000.
15. McRae, B. L., Nagai, T., Semnani, R. T., van Seventer, J. M., and van Seventer, G. A. Interferon-α and -β inhibit the in vitro differentiation of immunocompetent human dendritic cells from CD14(+) precursors. Blood, 96: 210-217, 2000.
16. Lehner, M., Felzmann, T., Clodi, K., and Holter, W. Type I interferons in combination with bacterial stimuli induce apoptosis of monocyte-derived dendritic cells. Blood, 98: 736-742, 2001.
17. Mattei, F., Schiavoni, G., Belardelli, F., and Tough, D. F. IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation. J. Immunol., 167: 1179-1187, 2001.
18. Maffei, A., Ayello, J., Skerrett, D., Papadopoulos, K., Harris, P., and Hesdorffer, C. A novel closed system utilizing styrene copolymer bead adherence for the production of human dendritic cells. Transfusion, 40: 1419-1420, 2000.
19. Romani, N., Reider, D., Heuer, M., Ebner, S., Kampgen, E., Eibl, B., Niederwieser, D., and Schuler, G. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J. Immunol. Methods, 196: 137-151, 1996.
20. Reddy, A., Sapp, M., Feldman, M., Subklewe, M., and Bhardwaj, N. A monocyte conditioned medium is more effective than defined cytokines in mediating the terminal maturation of human dendritic cells. Blood, 90: 3640-3646, 1997.
21. Harris, P. E., Maffei, A., Colovai, A. I., Kinne, J., Tugulea, S., and Suciu-Foca, N. Predominant HLA-class II bound self-peptides of a hematopoietic progenitor cell line are derived from intracellular proteins. Blood, 87: 5104-5112, 1996.
22. Choi, C., Kutsch, O., Park, J., Zhou, T., Seol, D. W., and Benveniste, E. N. Tumor necrosis factor-related apoptosis-inducing ligand induces caspase-dependent interleukin-8 expression and apoptosis in human astroglioma cells. Mol. Cell. Biol., 22: 724-736, 2002.
23. Wu, M., Das, A., Tan, Y., Zhu, C., Cui, T., and Wong, M. C. Induction of apoptosis in glioma cell lines by TRAIL/Apo-21. J. Neurosci. Res., 61: 464-470, 2000.
24. Hoffmann, T. K., Meidenbauer, N., Dworacki, G., Kanaya, H., and Whiteside, T. L. Generation of tumor-specific T-lymphocytes by cross-priming with human dendritic cells ingesting apoptotic tumor cells. Cancer Res., 60: 3542-3549, 2000.
25. van de Vijver, M. J., Mooi, W. J., Wisman, P., Peterse, J. L., and Nusse, R. Immunohistochemical detection of the neu protein in tissue sections of human breast tumors with amplified neu DNA. Oncogene, 2: 175-178, 1988.
26. Blanco, P., Palucka, A. K., Gill, M., Pascual, V., and Banchereau, J. Induction of dendritic cell differentiation by IFN-α in systemic lupus erythematosus. Science (Wash. DC), 294: 1540-1543, 2001.
27. Iellem, A., Colantonio, L., Bhakta, S., Sozzani, S., Mantovani, A., Sinigaglia, F., and D'Ambrosio, D. Inhibition by IL-12 and IFN-α of I-309 and macrophage-derived chemokine production upon TCR triggering of human Th1 cells. Eur. J. Immunol., 30: 1030-1039, 2000.
28. Tomiyama, H., Matsuda, T., and Takiguchi, M. Differentiation of human CD8(+) T cells from a memory to memory/effector phenotype. J. Immunol., 168: 5538-5550, 2002.
29. Gardella, S., Andrei, C., Lotti, L. V., Poggi, A., Torrisi, M. R., Zocchi, M. R., and Rubartelli, A. CD8(+) T lymphocytes induce polarized exocytosis of secretory lysosomes by dendritic cells with release of interleukin-1β and cathepsin D. Blood, 98: 2152-2159, 2001.
30. Joseph, S. B., Miner, K. T., and Croft, M. Augmentation of naive. Th1 and Th2 effector CD4 responses by IL-6, IL-1 and TNF. Eur. J. Immunol. 28: 277-289, 1998.
31. Ge, Q., Palliser, D., Eisen, H. N., and Chen, J. Homeostatic T cell proliferation in a T cell-dendritic cell coculture system. Proc. Natl. Acad. Sci. USA, 99: 2983-2988, 2002.
32. Niedbala, W., Wei, X., and Liew, F. Y. IL-15 induces type 1 and type 2 CD4+ and CD8+ T cells proliferation but is unable to drive cytokine production in the absence of TCR activation or IL-12/IL-4 stimulation in vitro. Eur. J. Immunol., 32: 341-347, 2002.
33. Luft, T., Jefford, M., Luetjens, P., Hochrein, H., Masterman, K. A., Maliszewski, C., Shortman, K., Cebon, J., and Maraskovsky, E. IL-1 β enhances CD40 ligand-mediated cytokine secretion by human dendritic cells (DC): a mechanism for T cell-independent DC activation. J. Immunol., 168: 713-722, 2002.
34. Denzin, L. K., Sant'Angelo, D. B., Hammond, C., Surman, M. J., and Cresswell, P. Negative regulation by HLA-DO of MHC class II-restricted antigen processing. Science (Wash. DC), 278: 106-109, 1997.
35. Kayagaki, N., Yamaguchi, N., Nakayama, M., Eto, H., Okumura, K., and Yagita, H. Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: a novel mechanism for the antitumor effects of type I IFNs. J. Exp. Med., 189: 1451-1460, 1999.
36. Fanger, N. A., Maliszewski, C. R., Schooley, K., and Griffith, T. S. Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). J. Exp. Med., 190: 1155-1164, 1999.
37. Liu, S., Yu, Y., Zhang, M., Wang, W., and Cao, X. The involvement of TNF-α-related apoptosis-inducing ligand in the enhanced cytotoxicity of IFN-β-stimulated human dendritic cells to tumor cells. J. Immunol., 166: 5407-5415, 2001.
38. Berard, F., Blanco, P., Davoust, J., Neidhart-Berard, E. M., Nouri-Shirazi, M., Taquet, N., Rimoldi, D., Cerottini, J. C., Banchereau, J., and Palucka, A. K. Cross-priming of naive CD8 T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cells. J. Exp. Med., 192: 1535-1544, 2000.